Positive Troponin in Diabetic Ketoacidosis without Evident Acute Coronary Syndrome Predicts Adverse Cardiac Events
Open Access
- 7 February 2008
- journal article
- research article
- Published by Wiley in Clinical Cardiology
- Vol. 31 (2), 67-71
- https://doi.org/10.1002/clc.20167
Abstract
Background Elevated troponin I has been associated with increased mortality in critically ill patients without acute coronary syndrome (ACS). However, the prognostic significance of troponin elevation in patients with diabetic ketoacidosis (DKA) without evident ACS has not been studied. Methods Retrospective study of all patients admitted to a U.S. tertiary center between 01/98 and 12/00 with DKA and had troponin I level measured. Patients with evidence of ACS or who met the American College of Cardiology/European Society of Cardiology (ACC/ESC) definition for myocardial infarction were excluded. Baseline characteristics, cardiac evaluation and 2 year major adverse coronary event (MACE) rate were compared between patients with positive and negative troponin. Results Ninety‐six patients fulfilled the inclusion criteria of this study, 26 had positive troponin. There were no differences in baseline characteristics between the two groups. After a 2 year follow‐up, there was significantly increased mortality in patients with elevated troponin (50.0% versus 27.1%, hazard‐ratio (HR) 2.3, 95% confidence intraval (CI) 1.2–4.8, p = 0.02). Patients with elevated troponin also had significantly increased MACE rate at 2 years (50.0% versus 28.6%, HR 2.6, 95% CI 1.3–5.3, p = 0.007) driven primarily by mortality. Using Cox Proportional Hazard Analysis, elevated troponin was a predictor of increased MACE after adjusting for confounding variables. (Adjusted HR 2.3, 95% CI 1.1–4.6, p = 0.02) Conclusions Elevated troponin I in diabetic patients admitted with DKA identifies a group at very high risk for future cardiac events and mortality. Whether cardiac risk stratification of these patients will improve long term outcome remains to be studied. CopyrightKeywords
This publication has 22 references indexed in Scilit:
- Prognostic value of low-level cardiac troponin-I elevations in patients without definite acute coronary syndromesAmerican Heart Journal, 2004
- Detection of Silent Myocardial Ischemia in Asymptomatic Diabetic SubjectsDiabetes Care, 2004
- Hyperglycemic Crises in Patients With Diabetes MellitusDiabetes Care, 2003
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Cardiac Troponin T Predicts Mortality in Patients With End-Stage Renal DiseaseCirculation, 2000
- Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction: The Joint European Society of Cardiology/ American College of Cardiology CommitteeJournal of the American College of Cardiology, 2000
- Independent Prognostic Value of Cardiac Troponin T in Patients With Confirmed Pulmonary EmbolismCirculation, 2000
- Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial InfarctionThe New England Journal of Medicine, 1998
- Elevation of troponin I levels in patients without evidence of myocardial injuryJAMA, 1997
- Cardiac-Specific Troponin I Levels to Predict the Risk of Mortality in Patients with Acute Coronary SyndromesThe New England Journal of Medicine, 1996